Overview

The aim of this study is to investigate the effects of thoracolumbar fascia mobilization and ultrasound-guided thoracolumbar interfascial 5% dextrose injection on pain, range of motion, disability, quality of life, proprioception, and fascial thickness and echogenicity in patients with nonspecific chronic low back pain.

-Primary Objective: The primary objective is to evaluate the effects of these interventions on pain, functional status and range of motion.

-Secondary Objective: The secondary objective is to assess the long-term effects on quality of life, proprioception, fascial thickness, and echogenicity.

Eligibility

Inclusion Criteria:

1. Male or female patients aged 18 to 65 years
2. Presence of low back pain lasting longer than 3 months
3. No adequate response to medical treatment
4. Voluntary participation in the study

Exclusion Criteria:

1. Age below 18 or above 65 years
2. Body mass index (BMI) greater than 30 kg/m²
3. Pregnancy or breastfeeding
4. Presence of coagulation disorders
5. History of spinal surgery
6. Presence of inflammatory or malignant diseases
7. Local infection at the spine or injection site
8. Presence of lumbar disc pathology causing radiculopathy
9. Presence of spinal stenosis, spondylolysis, or spondylolisthesis
10. Participation in physical therapy or any manual therapy within the past 6 months
11. Receiving lumbar injections within the past 6 months
12. History of allergy to injection materials
13. Refusal to participate in the study